For gastric cancer patients with lymph node metastasis, highly expressed CARM1 is associated with poor OS, FP and PPS prognosis (Table S1, see Additional file 4). This evidence concerns the gene CARM1 and metastatic malignant neoplasm in the lymph nodes.